General Information of the Compound
Compound ID |
CP0036230
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(2R,3R,4R,5S)-2-(Hydroxymethyl)piperidine-3,4,5-triol, 10
Show/Hide
|
||||||||||||||||||
Synonyms |
(2R,3R,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol
1,5-Deoxy-1,5-imino-D-mannitol
1,5-Dideoxy-1,5-imino-D-glucitol
1-DEOXYNOJIRIMYCIN
1-Deoxy-Nojirimycin
19130-96-2
3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2R,3R,4R,5S)-
3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2R-(2alpha,3beta,4alpha,5beta))-
5-Amino-1,5-dideoxy-D-glucopyranose
AK151410
C6H13NO4
CHEBI:44369
CHEMBL307429
D-1-deoxynojirimycin
DNJ
DUVOGLUSTAT
Deoxynojirimycin
FZ56898FLE
Moranolin
Moranoline
UNII-FZ56898FLE
deoxynojirimycin
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C6H13NO4
|
||||||||||||||||||
Molecular Weight |
163.173
|
||||||||||||||||||
Canonical SMILES |
OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C6H13NO4/c8-2-3-5(10)6(11)4(9)1-7-3/h3-11H,1-2H2/t3-,4+,5-,6-/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
LXBIFEVIBLOUGU-JGWLITMVSA-N
|
||||||||||||||||||
CAS |
19130-96-2
70956-02-4
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound